Yüklüyor......
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report
BACKGROUND: Hereditary hemorrhagic telangiectasia is an inherited autosomal dominant disease presenting with recurrent bleeding episodes and iron deficiency anemia due to vascular malformations. Hereditary hemorrhagic telangiectasia is associated with an increased risk of stroke, gastrointestinal bl...
Kaydedildi:
Yayımlandı: | Wien Klin Wochenschr |
---|---|
Asıl Yazarlar: | , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Springer Vienna
2016
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318479/ https://ncbi.nlm.nih.gov/pubmed/27878613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-016-1124-4 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|